Biogen (BIIB) Stock
Biogen (BIIB) closed at $253.40 on Nov 13, 2026; its Tenet Score is 39 of 100 against 297 Healthcare peers.
4 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $253.40
- Nov 13, 2026
- Market cap
- $37.5B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- P/E
- 107.8×
- price ÷ earnings
- 52-week range
- 160.36 – 261.00
- low → high · as of close, Nov 13, 2026
- Tenet Score
- 39/100
- Weak · 297 Healthcare peers
Industry: Drugs
Biogen Inc scores 39/100. Weak. Financial health is the soft spot, trading at 108× earnings versus 297 Healthcare peers.
Tenet Score · vs sector
n=297Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Munger Compounders
- ✕ Magic Formula
- ✕ Graham Defensive
- ~ Quality Compounder
13F flows & insider trades land here.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal m…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Idexx Laboratories, Inc.IDXX | 52 | $55.5B |
| Teva- Pharmaceutical Industries Ltd.TEVA | 34 | $51.9B |
| BeOne Medicines LtdONC | 64 | $47.6B |
| Revolution Medicines IncRVMD | 39 | $37.3B |
| Zoetis IncZTS | 59 | $34.1B |
| Illumina IncILMN | 51 | $31.3B |
| Roivant Sciences LtdROIV | 42 | $28.6B |
| Insmed IncINSM | 33 | $26.6B |
| United Therapeutics CorpUTHR | 72 | $25.2B |
| Incyte Corp.INCY | 60 | $24.7B |
Compare Biogen with
Common questions
What sector and industry is Biogen in?
Biogen is in the Healthcare sector and the Drugs industry.
What is Biogen's Tenet Score?
Biogen's Tenet Score is 39 out of 100, ranked against 297 Healthcare peers as of Nov 13, 2026.




